James P Boylan's Net Worth

$0

Estimate Recalculated Sep 18, 2024 04:17PM EST

Who is James P Boylan?

James P Boylan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Compass Therapeutics, Inc., and Immunome Inc..

SEC CIK

James P Boylan's CIK is 0001953094

Past Insider Trading and Trends

2024 was James P Boylan's most active year for acquiring shares with 2 total transactions. James P Boylan's most active month to acquire stocks was the month of February. 2023 saw James P Boylan paying a total of $0.00 for 41,538 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 8
Form 3
—
0
—
—
0
No matching records found

Immunome Inc. (IMNM) Snapshot price: $13.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Oct 27
Form 3
—
0
—
—
0
No matching records found

Zenas BioPharma, Inc. (ZBIO) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 12
Form 3
—
0
—
—
0
No matching records found